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DNA damageThe Sin3a/HDAC co-repressor complex is a critical regulator of transcription networks that govern cell cycle
control and apoptosis throughout development. Previous studies have identiﬁed Sin3a as essential for embryonic
development around the time of implantation, during which the epiblast cell cycle is uniquely structured to
achieve very rapid divisionswith little tolerance of DNA damage. This study investigates the speciﬁc requirement
for Sin3a in the early mouse embryo and shows that embryos lacking Sin3a suffer unresolved DNA damage and
acute p53-independent apoptosis speciﬁcally in the E3.5–4.5 epiblast. Surprisingly, Myc and E2F targets in
Sin3a-null ICMs are downregulated, suggesting a central but non-canonical role for Sin3a in regulating the
pluripotent embryonic cell cycle. ES cells deleted for Sin3a mount a DNA damage response indicative of
unresolved double-strand breaks, profoundly arrest at G2, and undergo apoptosis. These results indicate
that Sin3a protects the genomic integrity of pluripotent embryonic cells and governs their unusual cell
cycle.
© 2011 Elsevier Inc. All rights reserved.Introduction
Robust mechanisms are required to protect the genomic integrity
of pluripotent embryonic cells that give rise to the entire organism
and future generations through the germ line. Consequently, embryonic
stem (ES) cells and, by inference, cells of the inner cell mass (ICM)
have considerably lower mutation frequencies than somatic cells
(Hong et al., 2007) and are highly sensitive to DNA damage and
other genotoxic stresses (de Waard et al., 2003; Roos et al., 2007;
Van Sloun et al., 1999).
The intolerance of ES cells toward DNA damage is facilitated by
elaborate mechanisms compromising the G1 damage checkpoint
and abating the opportunity for repair, routing damaged cells to the
more stringent, intact G2/M checkpoint and ultimately apoptosis. In
self-renewing ES cells, checkpoint proteins such as p53 (encoded by
the Trp53 gene) are sequestered almost entirely in the cytosol, thus
preventing effective regulation of their nuclear targets in response
to DNA damage (Aladjem et al., 1998; Hong and Stambrook, 2004;r Stem Cell Research and MRC
ine, University of Cambridge,
Hendrich).
rvard, Cambridge, MA 02412,
rights reserved.Lin et al., 2005; Solozobova et al., 2009). Indeed, ES cells deleted for
Trp53 readily undergo apoptosis in response to DNA damage with
kinetics similar to wild-type cells (Aladjem et al., 1998; Lin et al.,
2005; Solozobova et al., 2009), despite a failure to induce canonical
somatic targets of p53.
As with the response to DNA damage, models of cell cycle control
in the epiblast are largely inferred from studies of mouse ES cells (for
reviews see (Orford and Scadden, 2008; White and Dalton, 2005)).
The extremely rapid divisions of mouse ES cells are accomplished
by the effective elimination of the early G1 phase. Unlike in somatic
cells, constitutively high expression of Cyclin E1 stimulates Cdk2
activity throughout the entire ES cell cycle, thereby maintaining Rb
in a hyperphosporylated, inactive state and bypassing both the
restriction point (R) and the need for mitogen stimulation of Cyclin
D-Cdk4/6 activity (Burdon et al., 2002; Savatier et al., 1994; White
et al., 2005). This constitutive inactivation of Rb results in continual
activation by E2f1 of its targets, including Cyclin E1 (MGI: Ccne1)
and the replication machinery, thus rapidly driving ES cells from mi-
tosis into S phase regardless of any damage or stress that might have
occurred.
A key regulator of the Myc, E2F, and p53 transcription networks
that govern cell cycle control and apoptosis throughout development
is the Sin3a co-repressor complex (McDonel et al., 2009; Silverstein
and Ekwall, 2005). This conserved complex is scaffolded by the
Sin3a protein, which binds class I histone deacetylases (HDACs)
63P. McDonel et al. / Developmental Biology 363 (2012) 62–73Hdac1 and Hdac2 (Laherty et al., 1997) and a diverse array of
sequence-speciﬁc repressors via its paired amphipathic helices
(Le Guezennec et al., 2006; Sahu et al., 2008), thus recruiting HDAC
activity to target promoters.
Sin3a function is essential for the growth and viability of mouse em-
bryonic ﬁbroblasts (MEFs). Deletion of Sin3a in MEFs results in a pro-
found growth defect, signiﬁcant G2/M accumulation, and increased
apoptosis in conjunction with de-repression of hundreds of Myc, E2f1,
E2f4, and p53 targets that control cell cycle progression, DNA replica-
tion and repair, and cell death (Dannenberg et al., 2005). Interestingly,
while the induction of p21Cip (MGI: Cdkn1a) in response to Sin3a dele-
tion requires p53, the growth arrest, replication defects, and apoptosis
were not alleviated by either ablation or functional inactivation of
p53. Furthermore, genes involved in both non-homologous end-
joining (NHEJ) and homologous recombination (HR) repair pathways
were aberrantly upregulated in MEFs lacking Sin3a (Dannenberg et al.,
2005), suggesting a novel role in balancing the relative activities of
these two double-strand break (DSB) repair strategies in addition to
its reported chromatin-modifying functions during NHEJ (Jazayeri
et al., 2004) and DNA replication (Aparicio et al., 2004) in yeast.
Genetic studies have shown that Sin3a is required for early mouse
embryonic development between E3.5 and gastrulation at E6.5
(Cowley et al., 2005; Dannenberg et al., 2005). Similarly, knock-
down of Sin3a by siRNAs resulted in severely impaired proliferation
in ES cells (Fazzio et al., 2008). However, as outlined above, many of
the genes overexpressed in Sin3a−/−MEFs that led to growth defects
and apoptosis are already highly expressed in early embryonic cells,
and thus their de-repression in the ICM or ES cells is not necessarily
expected to have such adverse effects. Therefore, the mechanisms un-
derlying this embryonic requirement for Sin3a are not at all clear.
To better understand the requirement for Sin3a/HDAC complexes
in early mammalian embryogenesis, we examined in detail embryos
and ES cells deleted for Sin3a. We found that Sin3a is absolutely re-
quired for proliferation and survival of cells in the ICM as embryos
implant, but cells in the trophectoderm lineage appeared largely
normal in Sin3a−/− embryos. We identify a number of proteins
interacting with Sin3a in ES cells, further implicating the complex
in cell cycle control and the DNA damage response. We propose
that Sin3a is essential to maintain both the unusual cell cycle of plu-
ripotent embryonic cells and their genomic integrity.Materials and methods
Mice and embryos
Sin3aFlox/+ ES cells were a kind gift of Gregory David (New York). ES
cells were injected into C57Bl/6 host blastocysts to generate
chimeric mice using standard methods (Hogan et al., 1994). Resulting
Sin3aFlox/+ mice were then either intercrossed to create a homozygous
Sin3aFlox/Flox line or crossed to mice expressing a Cre transgene under
the control of the Sox2 promoter (Hayashi et al., 2002), kindly provided
by Jennifer Nichols (Cambridge).Maternal contribution of the Cre protein
to the zygote resulted in recombination between the LoxP sites and
creation of Sin3a+/− mice, which were maintained as a heterozygote
stock by outcrossing to C57Bl/6 mice. Mice were genotyped in a
duplex PCR reaction using the following primers: S3AP2, CAGATCC-
TATTCCAGGTGTCAAAG; S3AP6, GGGGGAATGCTGTGTTTTAGGTATG; and
S3AP12, CAAGTTCATCAGATTCCCAC. Genotyping of embryos was per-
formed using nested PCR consisting of 25 cycles with standard geno-
typing primers, followed by 20 cycles with the following primers:
S3AP9, CATCCTTCCCAGCCTTCAT; S3AP10, TACAAAGCCAGCCCTGAGAC;
and S3AP11, CAAGATGGCCTTGAACTTTTGG.
ES cell derivation, ICM outgrowths in ERK inhibitor, and induction
of diapause were all performed as described (Buehr and Smith, 2003;
Nichols et al., 2009).All mice were housed under standard conditions. All procedures
were covered by a license granted by the UK Home Ofﬁce and were
approved by institutional ethics committees.
Immunoﬂuorescence
Embryos were ﬁxed in 2.5% paraformaldehyde, permeabilised in
0.25% Triton X-100 in PBS, and blocked in PBS containing either 3% don-
key serum, 0.1% BSA, and 0.01% Tween-20 or 10% fetal calf serum and
0.1% Triton X-100. The primary antibodies were applied in blocking so-
lution at 4 °C overnight, and secondary antibodies were applied for an
hour at room temperature. Primary antibodies usedwere the following:
anti-Sin3a (1/200, sc-768, Santa Cruz Biotechnology), anti-Oct4 (1/100,
sc-5279 and sc-8628, Santa Cruz Biotechnology), anti-Nanog (1/250,
ab21603, Abcam and RCAB0002P-F, Cosmo Bio Co), anti-Cdx2 (1/200,
Cdx2-88, BioGenX), anti-Eomes (1/200, ab23345, Abcam), anti-Gata4
(1/200, sc-1237, Santa Cruz Biotechnology), anti-Mi-2ß (1/200, 39289,
Active Motif), anti-activated Caspase 3 (1/500, AF835, R&D Systems),
and anti-phospho-H2A.X (S139) (1/500, 05-636, Millipore). For the
phoshpo-H2A.X (γH2AX) quantitation, mean staining intensity values
obtained from confocal images weremeasured for DAPI-positive nuclei
using Volocity software (Perkin Elmer) for three wild-type embryos,
eight heterozygous embryos, and six null embryos. Cells were scored
as being ICM or TE based upon Oct4 expression levels. This resulted in
78, 184, and 96 wild-type, heterozygous, or null ICM cells respectively,
and 118, 250, and 216wild-type, heterozygous and null TE cells, respec-
tively. Mean intensity values of anti-H2AX staining were used to build
box plots (http://www.physics.csbsju.edu/stats/display.distribution.
html). P-values were calculated using a single tailed Mann–Whitney
test (http://faculty.vassar.edu/lowry/utest.html).
Single-ICM gene expression analyses
Individual ICMs from Sin3a+/− intercrosses were dissected away
from trophectoderms by immunosurgery (Nagy et al., 2006) at 3.5 dpc
and placed into either ﬁrst-strand buffer [1× Superscript III buffer (Invi-
trogen), 0.5% NP-40 (Pierce), 10 mM dNTP mixture (Roche), 3.4 nM
MO4dT30 primer (AAGCAGTGGTATCAACGCAGAGTGGCCATTACGGCCGT
AC-(dT)30) (Osawa et al., 2005), 1 mM DTT (Invitrogen), 5 U SuperRNa-
seIN (Ambion), 7.5 U PrimeRNase inhibitor (Eppendorf)] or miRNA lysis
buffer [1 mg/mL BSA (NEB), 0.5% NP-40 (Pierce)], snap-frozen on dry
ice, and stored at –80 °C. Trophectoderms from each embryo were lysed
in PCR lysis buffer [1× ThermoPol buffer (NEB), 0.45% Igepal CA-630
(Sigma), 0.45% Tween 20 (Sigma), 200 μg/mL Proteinase K (Roche)] at
55 °C for 2 h followed by inactivation for 15 min at 95 °C and genotyped
for Sin3a by duplex PCR as described above.
For cDNA synthesis, ICMs frozen in ﬁrst-strand buffer were lysed at
65 °C for 5 min, diluted 1:10 in 4.5 μL ﬁrst-strand buffer, and re-heated
to 65 °C for 5 min. Primer was allowed to anneal at 45 °C for 2 min be-
fore addition of 0.5 μL of Superscript III and incubation at 45 °C for
15 min. The reaction was inactivated at 65 °C for 10 min. Unannealed
primer was digested by the addition of 4 U Exonuclease I (Thermo Fish-
er Scientiﬁc) in 1.0 μL (ﬁnal concentration of 6.7 mMMgCl2) and incu-
bated at 37 °C for 30 min before inactivation at 80 °C for 25 min.
Removal of the RNA template and polyadenylation of the cDNAwas car-
ried out concurrently by the addition of 5 U RNaseH (Invitrogen), 2.6 μL
of 5× terminal deoxynucleotidyltransferase buffer (Promega) supple-
mented with 1.5 mM dATP (Roche), and 30 U terminal deoxynucleoti-
dyltransferase (TdT) (Promega) followed by incubation for 15 min at
37 °C before inactivation at 65 °C for 10 min. 4 μL of polyadenylated
cDNA was used as template for PCR ampliﬁcation in 1× ExTaq buffer
(TaKaRa), 0.65 mM dNTP (Roche), 8.25 μM MO4dT30 primer, and 5 U
ExTaq (TaKaRa) by incubating at 94 °C for 1 min, 50 °C for 2 min, and
72 °C for 2 min to allow second-strand synthesis. Subsequently, 35 cy-
cles of ampliﬁcation were performed by incubating at 94 °C for 30 s,
60 °C for 30 s, and 72 °C for 2 min. The ﬁrst round of ampliﬁcation was
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second round of ampliﬁcation was performed in duplicate as above by
using 2 μL of the pooled ampliﬁed cDNA as template. The ampliﬁed
cDNA was again pooled before puriﬁcation with the QIAquick PCR
puriﬁcation kit (Qiagen). The eluate was diluted 1:50 in water for
subsequent qPCR using an Applied Biosystems StepOne Plus PCR sys-
tem with Roche SYBR Green Master reagents and primers listed in
Suppl. Table 1.
Reverse transcription and qPCR analysis of miRNAs were con-
ducted exactly as described (Tang et al., 2006b), using only the
gene-speciﬁc forward primers listed in Suppl. Table 1 for the cDNA
ampliﬁcation step.
ES cells
Sin3aFlox/− ES cells were derived from mixed C57/129 blastocysts
and cultured in ES cell medium supplemented with 10% fetal bovine
serum and recombinant human LIF on gelatin-coated ﬂasks, as de-
scribed (Smith, 1991). Stable integration of a plasmid expressing
Cre-ERT2-IRES-Puro from a CAG promoter was achieved by electroporat-
ing 5×107 Sin3aFlox/− ES cells with 80 μg linearised vector, plating of seri-
al dilutions, and selection with 1 μg/mL puromycin for 6 days until
colonies were clearly visible. Clones were picked into individual gelatin-
coated wells and subsequently expanded under puromycin selection. In
transfected lines, Cre was translocated into the nucleus by the addition
of 400 nM 4-hydroxytamoxifen. Apoptosis was detected in unﬁxed ES
cells using Alexa Fluor 488 Annexin V (Invitrogen) following the manu-
facturer's instructions, except for including 1 μg/mL DAPI as a live/dead
discriminator in place of propidium iodide. Western blots were
performed on total ES cell lysates prepared in Laemmli buffer added
directly to culture dishes. The following antibodies were used: anti-
Sin3a (1/500, sc-994, Santa Cruz), anti-phospho-histone H2A.X
(Ser139) (1/2000, 05-636, Millipore), anti-phospho-SMC1 (Ser966)
(1/2000, generous gift of John Rouse, University of Dundee), anti-
phospho-53BP1 (Ser166) (1/320, S651B, generous gift of John Rouse,
University of Dundee) and anti-α-tubulin (1/1000, sc-53646, Santa Cruz).
Cell cycle analysis by ﬂow cytometry
At the indicated time points, approximately 1–2×105 ES cells were
trypsinised,washed in PBS, andﬁxed dropwise into ice-cold 70% ethanol.
Fixed cells were washed twice with wash buffer (PBS plus2.5% Fetal
Bovine Serum), then permeabilised in wash buffer containing 0.25%
Triton X-100 for 15 min on ice. Permeabilised cells were then incubated
for 3 h at room temperature inwash buffer containing 100 μg/mLmouse
anti-phospho-histone H3 (S10) antibody (Sigma), washed twice, and
stained with an Alexa Fluor 488-conjugated anti-mouse secondary anti-
body (Invitrogen) for 30 min. After twomore washes, cells were stained
with 50 μg/mL propidium iodide (PI) and ﬂuorescence was measured
using a FACSCalibur ﬂow cytometer (BD Biosciences). At least 10,000
gated events were recorded for each sample. Positive/negative scoring
for phospho-histone H3 was determined by comparison to control cells
stained with PI alone and applied uniformly across all samples.
P-values were calculated using Fisher's exact test.
Sin3a-3xFLAG expression and immunoprecipitation
Sin3a cDNA was synthesised from ES cell total RNA using reverse
transcription and cloned in-frame into the C-terminal 3x-FLAG expres-
sion vector pCAG-A3XF-iH. Following transfection into E14tg2a ES
cells using Lipofectamine 2000 (Invitrogen) and 6 days of selection
with 100 μg/mL hygromycin, resistant colonies expressing either
Sin3a-3xFLAG or 3xFLAG alone (empty vector) were expanded and
assayed for endogenous Sin3a and Sin3a-3xFLAG expression levels by
western blot. Two independent Sin3a-3xFLAG clones and two vector-
only clones were chosen and expanded for preparation of nuclearextracts. Brieﬂy, cells were harvested by trypsinisation and rinsed
twice in ice-cold PBS, then once in ice-cold lysis buffer (10 mM
HEPES-KOH pH 7.6, 10 mM KCl, 1.5 mM MgCl2, 0.5 mM PMSF, 0.5 mM
DTT). Cells were suspended in lysis buffer for 10 min on ice, then gently
lysed using a glass dounce homogeniser. Nuclei were pelleted by centri-
fugation at 3300 g and resuspended in low-salt nuclear extract buffer
(25 mM HEPES-KOH pH 7.6, 20 mM KCl, 1.5 mM MgCl2, 10% glycerol,
0.5 mM PMSF, 0.5 mM DTT) and then lysed by adding KCl to 450 mM
and Igepal CA-630 to 0.15% and rotating at 4 °C for 1 h. Insolublematerial
was pelleted by centrifugation for 30 min at 20,000 g, and the superna-
tant was aliquoted and ﬂash-frozen in liquid nitrogen.
For immunoprecipitations, 13–15 mg nuclear extract was diluted
in IP buffer [25 mM HEPES-KOH pH 7.6, 140 mM KCl, 10% glycerol,
0.1% Igepal CA-630, 0.5 mM EDTA, 0.5 mM DTT, 1X Protease Inhibitor
Cocktail III (Calbiochem)], pre-cleared against protein G sepharose,
and then rocked for 4 hours at 4 °C with 75 μL (packed) anti-FLAG
M2 resin (Sigma). Following extensive washes in IP buffer containing
250 mM KCl, Sin3a complexes were eluted 3 times in IP buffer con-
taining 200 μg/mL 3× FLAG peptide for 30 min. Eluates were pooled
and precipitated with trichloroacetic acid. The pellets were washed in
acetone and solubilised in Laemmli buffer for SDS-PAGE on separate
4–12%Bis–Tris Novex (Invitrogen) polyacrylamide gels for each sample.
Mass spectrometric analysis
1D SDS-PAGE gel lanes were cut into 2 mm slices using an auto-
matic gel slicer and subjected to in-gel reduction with DTT alkylation
with iodoacetamide, and digestion with trypsin (Promega, sequenc-
ing grade), essentially as described (Wilm et al., 1996). Nanoﬂow
LC-MS/MS was performed on an 1100 series capillary LC system
(Agilent Technologies) coupled to an LTQ-Orbitrap mass spectrome-
ter (Thermo) operating in positive mode and equipped with a nanos-
pray source. Peptide mixtures were trapped on a ReproSil C18
reversed phase column (Dr Maisch GmbH; column dimensions
1.5 cm×100 μm, packed in-house) at a ﬂow rate of 8 μL/min. Peptide
separation was performed on ReproSil C18 reversed phase column
(Dr Maisch GmbH; column dimensions 15 cm×50 μm, packed in-
house) using a linear gradient from 0% to 80% B (A=0.1% formic
acid; B=80% (v/v) acetonitrile, 0.1% formic acid) over 70 min at a
constant ﬂow rate of 200 nL/min using a splitter. The column eluent
was directly sprayed into the ESI source of the mass spectrometer.
Mass spectra were acquired in continuum mode; fragmentation of
the peptides was performed in data-dependent mode. Peak lists
were automatically created from raw data ﬁles using the Mascot Dis-
tiller software (version 2.3; MatrixScience). The Mascot search algo-
rithm (version 2.2, MatrixScience) was used for searching against
the SwissProt FASTA protein sequence database (version Swis-
sProt_56.4, taxonomy: Mus musculus). The peptide tolerance was set
to 10 ppm and the fragment ion tolerance was set to 0.8 Da. A maxi-
mum number of 2 missed cleavages by trypsin were allowed and car-
bamidomethylated cysteine and oxidised methionine were set as
ﬁxed and variable modiﬁcations, respectively. The Mascot score cut-
off value for a positive protein hit was set to 65. Individual peptide
MS/MS spectra with Mascot scores below 40 were checked manually
and either interpreted as valid identiﬁcations or discarded. Typical
contaminants, also present in immunopuriﬁcations using beads coat-
ed with pre-immune serum or antibodies directed against irrelevant
proteins, were omitted from the table.
Results
Sin3a is required for epiblast formation
To investigate the function of Sin3a in pluripotent cells, we ﬁrst
investigated the role of Sin3a in pre- and peri-implantation develop-
ment in mice. Nuclear Sin3a protein is visible in both wild-type and
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the egg and that this maternal protein persists through the ﬁrst few
cleavage divisions (Fig. 1A). By the 8-cell stage nuclear Sin3a is less
apparent in mutant embryos than in wild-type littermates, and by
the 16-cell stage the maternal protein has largely been depleted and
null embryos show no nuclear Sin3a protein (Fig. 1B). At the
blastocyst stage Sin3a is expressed ubiquitously in wild-type and het-
erozygous embryos (Fig. 1B). Despite lacking any detectable Sin3a8-cell 
2-cell 
Mi2Sin3A DAPI
+
-
Oct4Sin3A
16-cell 
Phase B 
A 
Blastocyst 
C NanogOct4 Phase 
Fig. 1. Sin3a expression in preimplantation development. A.Maternal Sin3A protein (green) can
is shown inwhite and DAPI staining in blue. B. Staining of 8- and 16-cell embryos and early
heterozygotes, but loss of nuclear staining in Sin3a−/− embryos from the 8-cell stage onwa
Sin3a−/− blastocysts for the ICM markers Oct4 (red) and Nanog (green), for the trophectod
staining is shown to highlight segregation of the ICM and TE lineages. For all embryos theprotein, null blastocysts are able to cavitate and, as judged by patterns
of antibody staining for the Oct4, Nanog, and Cdx2 proteins, are able
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and trophectoderm (Fig. 1C). Indeed, Sin3a blastocysts were recovered
from heterozygote intercrosses at near Mendelian ratios (Table 1). As
maternal Sin3a is largely depleted by the 8-cell stage, these results indi-
cate that Sin3a does not have an essential role in cellular proliferation or
early cell fate speciﬁcation in late preimplantation stage embryos./+ 
/- 
+/+ 
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rds. Staining for Oct4 (red) and DAPI (blue) is also indicated. C. Staining wild-type and
ermmarker Cdx2 (pink), and for DAPI (blue). A panel showing both Nanog and Cdx2
genotypes are shown to the right. Scale bar=50 μm.
Table 1
Genotypes of pups and embryos produced by Sin3a heterozygote intercrosses at the in-
dicated stages of embryonic development or after weaning (3 weeks of age).
+/+ +/− −/− N
3.5 d.p.c 28 (28.6%) 49 (50.0%) 21 (21.4%) 98
4.5 d.p.c 25 (31.6%) 40 (50.6%) 14 (17.7%) 79
5.5 d.p.c 21 (32.8%) 39 (60.9%) 4 (6.3%) 64
Weaning 28 (35%) 52 (65%) 0 (0%) 80
Oct4 Eomes Gata4 
-/- 
+/+ 
Eomes Oct4  IPAD Phase 
-/- 
+/- 
B 
A 
C Eomes  IPAD Phase Gata4 
Oct4 
-/- 
+/- 
Fig. 2. Loss of ICM cells in peri-implantation Sin3a-null embryos. A. Heterozygote and
null 4.5 dpc embryos stained for Eomes (green), Oct4 (red) and Gata4 (purple). Scale
bar=50 μm. B. 5.5 dpc embryos of indicated genotypes stained for Eomes (green),
Oct4 (red) and DAPI (blue). Scale bar=100 μm. C. Sin3a+/− and Sin3a−/− embryos re-
covered after two days of diapause stained for Eomes (green), in the left hand panel,
and Oct4 (red), Gata4 (white) and DAPI (blue) in the middle panel. Phase image of
the embryos is shown in the right hand panel. Genotypes are indicated to the right.
Scale bar=50 μm.
66 P. McDonel et al. / Developmental Biology 363 (2012) 62–73Despite the apparently normal preimplantation development,
implanting Sin3a−/− embryos were recovered at sub-Mendelian ratios,
and those recovered were obviously smaller than their wild-type and
heterozygous littermates, with the Oct4- and Gata4-expressing cell
populations appearing to be particularly affected (Table 1, Fig. 2A, and
Fig. 3A right panel). Nevertheless, most embryos were able to implant,
indicating that trophectoderm cells do not require Sin3a to form an
attachment to the uterus, consistent with a previous report that seem-
ingly empty implantation sites could be identiﬁed at 6.5 dpc (Cowley
et al., 2005). By 5.5 dpc few mutant embryos were recovered, but
those identiﬁed appeared to have completely lost their embryonic com-
partment, as judged by Oct4 and Gata4 staining, and consisted entirely
of Eomes-expressing trophectoderm (Table 1; Fig. 2B). Therefore, we
conclude that Sin3a is absolutely required for the viability and/or prolif-
eration of epiblast cells in peri-implantation embryos.
We next wished to assess whether the speciﬁc loss of epiblast cells
in Sin3a mutant embryos was an intrinsic property of the embryo or
was induced externally during implantation. To distinguish these possi-
bilities, we ﬁrst examined the status of wild-type and mutant embryos
in which the preimplantation period was extended by inducing dia-
pause (Buehr and Smith, 2003). Strikingly, subjecting Sin3a−/− blasto-
cysts to diapause for two days resulted in complete loss of the ICM
(Fig. 2C), whereas wild-type (not shown) and heterozygous blastocysts
maintained their characteristic ICMmorphology. To remove blastocysts
from the uterine environment completely, blastocysts were ﬂushed
early on the fourth day and allowed to outgrow in standard ES cell
serum and LIF conditions. Consistent with a previous report (Cowley
et al., 2005), we found that Sin3a-null embryos were able to attach to
the substrate but completely failed to outgrow (data not shown).
Failure of blastocyst outgrowth could be due either to a general prolif-
eration defect or to a speciﬁc failure of the trophectoderm cells. To assess
the proliferation potential of pluripotent cells lacking Sin3a, embryos
were collected at the 8-cell stage and incubated in the presence of the
ERK inhibitor PD0325901 until the expanded blastocyst stage, as de-
scribed (Nichols et al., 2009). This prevented formation of hypoblast
in the resulting blastocysts, allowing us to isolate pure epiblasts after
immunosurgery. Outgrowth of isolated wild-type or heterozygous epi-
blasts in 2i media (Nichols et al., 2009) resulted in derivation of embry-
onic stem cell lines in all cases, but Sin3a−/− epiblasts failed to outgrow
(data not shown). Therefore, we conclude that Sin3a is required for the
expansion of pluripotent cell populations both in vivo and ex vivo.
Apoptosis speciﬁcally eliminates the epiblasts from embryos lacking
Sin3a
Our data thus far indicated a speciﬁc loss of the Sin3a-null plurip-
otent cell population during implantation, but little if any effect upon
trophectoderm cells. Sin3a activity has been shown to prevent p53-
independent apoptosis in murine embryonic ﬁbroblasts (MEFs)
(Cowley et al., 2005; Dannenberg et al., 2005). To determine whether
ICM cells of Sin3a−/− embryos were dying via apoptosis, pre- and
peri-implantation stage embryos were stained for activated
Caspase-3, a marker of apoptotic cells (Nicholson, 1999). Apoptosis
occurs at a very low rate in the ICM of wild-type blastocysts during
normal development (Jang et al., 2005). Consistent with this, we
saw that the vast majority of wild-type or Sin3a+/− blastocysts hadeither zero or one Caspase 3-positive cell (Fig. 3). By contrast, half
of the Sin3a−/− blastocysts had three or more Caspase 3-positive
cells, usually located in the ICM (Figs. 3A left panel, B). One day
later almost all wild-type or heterozygous embryos had zero or one
Caspase 3-positive cell, whereas over 80% of Sin3a−/− embryos
showed three or more Caspase 3-positive cells (Figs. 3A right panel,
B). Those embryos showing multiple apoptotic cells also showed little
or no Oct4 staining, consistent with death of ICM cells in the absence
of Sin3a (Fig. 3B). Therefore, we conclude that Sin3a is speciﬁcally re-
quired for survival of pluripotent cells in implanting blastocysts, but it is
not required for development of the trophectoderm until at least 5.5 dpc.
Apoptosis in Sin3−/− ICMs is independent of p53 activity
We next addressed whether the growth defect and apoptosis ob-
served in Sin3a−/− ICMs were the result of p53 activation of arrest
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for Sin3a were destined for apoptosis, they did not show induction of
the p53 targets p21 (cell cycle arrest), Apaf-1 [apoptosis, (Moroni et
al., 2001)], or Dram [autophagy and apoptosis, (Crighton et al., 2006)]
(Fig. 4B). By contrast, levels of both p21 and Dram transcripts showed
a dose-dependent reduction in Sin3a heterozygous and null ICMs, pos-
sibly indicating a previously unrecognised relationship between Sin3a
and these p53 targets in early embryonic cells. Our observations are
consistent with a previous report that MEFs deleted for Sin3a undergo
p53-independent apoptosis (Cowley et al., 2005) and suggest that the
cell death induced in pluripotent cells lacking Sin3a is exerted indepen-
dently of p53 activity.
Sin3a−/− ICMs fail to express key cell cycle promoting factors
To investigate the underlying causes of the growth and apoptosis
defects observed in Sin3a−/− embryos, we compared the transcript
levels of key cell cycle regulatory genes in wild-type, heterozygous,
and null ICMs at E3.5, the stage at which these phenotypes initially
emerged. We found that as early as E3.5 transcripts for key cell
cycle regulatory proteins were either not expressed or expressed at
substantially reduced levels in ICMs deleted for Sin3a as compared
with their wild-type or heterozygous counterparts (Fig. 4A). Most no-
tably, whereas Sin3a−/− ICMs express normal levels of Oct4 and
Nanog, they expressed nearly undetectable levels of E2f1 and one of
its key targets, Ccne1 (Cyclin E1), both of which are critical for driving
ES cells rapidly through G1(Fujii-Yamamoto et al., 2005; Stead et al.,
2002). Sin3a-null ICM cells also expressed less than half the wild-
type levels of the replication licensing factor Mcm2 and the principalmitotic cyclin Ccnb1 (Cyclin B1). The absence of transcripts for these
key cell cycle proteins makes it very unlikely that the cells would be
able to progress through DNA replication and mitosis.Sin3a−/− cell cycle misregulation and cell death phenotypes are not
caused by mis-expression of ESCC or Myc-regulated miRNAs
One potential explanation for decreased E2f1 levels and
p53-independent cell cycle disruption (and possibly the resulting
cell death) comes from recent studies on miRNA control of the cell
cycle, particularly in ES cells. Artiﬁcially high levels of c-Myc expres-
sion were shown in human B cells to induce the miR-20 family of
miRNAs as part of a feedback loop, resulting in a block in the transla-
tion of E2F1 transcripts (Zhang and Pugh, 2011). This effectively
mimics the E2F-inhibitory function of Rb and is expected to prevent
expression of E2F targets such as the G1 cyclins and replication fac-
tors such as Mcm2. Moreover, so-called "ES Cell Cycle Control" (or
ESCC) miRNAs in the miR-290 family stimulate ES cell proliferation
by indirectly activating c-Myc and N-Myc, and thus by extension
Myc targets, while also blocking p21 translation and inhibiting the
Myc inhibitor miRNA let-7 (Gilchrist et al., 2008, 2010; Kumar et al.,
2007). We therefore measured the levels of miRNAs in Sin3a−/−
ICMs as compared with wild-type littermate ICMs (Fig. 4C). Our
analysis of miRNAs in Sin3a-null ICMs revealed no induction of
miR17-5p nor increased expression of miR-20a or miR-290 family
miRNAs, thereby demonstrating that the apoptosis and repression
of Myc/E2F targets we observe in Sin3a null ICMs are not due to
misregulation of these miRNAs.
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Fig. 4. Disruption of cell cycle control gene expression in Sin3a−/− ICMs. A and B. The mean expression level of each indicated gene normalised to an internal standard (Gapdh) is
plotted on the Y-axis as fold-change relative to themean value for all wild-type samples (deﬁned as 1.0). Black bars are the relative values forwild-type, grey bars for Sin3a+/−, andwhite
bars for Sin3a−/−. Error bars represent the standard deviation from the mean among biological replicates. C. Mean relative expression of each indicated miRNA in Sin3a+/+ (black) and
Sin3a−/− (grey), normalised tomiR-16, is plotted on the Y-axis as fold-change relative to itsmean value in an arbitrarily chosen Sin3a+/+ sample processed in parallel. Error bars represent
standard deviation from the mean among biological replicates.
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pluripotent cells
In an effort to understandwhy pluripotent cells lacking Sin3a under-
go apoptosis, we created an ES cell line in which Sin3a could be deleted
conditionally. Multiple independent ES cell lines were derived from
mice harbouring a Sin3a allele that could be deleted conditionally
(Sin3aFlox/−) (Dannenberg et al., 2005). Resulting ES cell lines were
then stably transfectedwith a construct allowing expression of CreERT2,
in which the Cre recombinase is fused to a modiﬁed estrogen receptor
(Feil et al., 1997). Addition of 4-hydroxytamoxifen to Sin3aFlox/−:CreERT2
ES cells rapidly induced deletion of the ﬂoxed Sin3a allele (data not
shown) and loss of Sin3a protein (Fig. 5D). As was seen in ICM cells,
Sin3a−/− ES cells were not viable and began to die by apoptosis.
Propidium iodide staining and ﬂow cytometry showed a marked
accumulation of Sin3a-deleted cells with a 4 C DNA content, as com-
pared with heterozygous controls (Fig. 5A). Furthermore, the fraction
of 4 C cells entering mitosis, as assessed by the mitotic marker
phospho-histone H3 (Ser10), was signiﬁcantly (pb0.001) reduced
in Sin3a-deleted cells (Fig. 5B). Floating and attached cells in
tamoxifen-treated and untreated Sin3aFlox/−:CreERT2 cultures were
assayed for apoptosis by probing with ﬂuorescently labelled Annexin
V, which binds to phosphatidyl serine on the cell membrane of apo-
ptotic cells. By 36 h after tamoxifen addition, approximately 68% of
ES cells deleted for Sin3a undergo apoptosis, as compared with ap-
proximately 12% of untreated cells (Fig. 5C). Taken together, theseresults indicate that cells lacking Sin3a arrest at the G2/M checkpoint
and die by apoptosis.
Given the lack of a functional G1/S damage checkpoint in ES cells,
and prior gene expression evidence implicating Sin3a in DSB repair
pathways in somatic cells, we hypothesised that the observed G2
arrest in ES cells upon loss of Sin3a could arise from failure to resolve
DSBs. Indeed, probing whole-cell lysates from untreated and
tamoxifen-treated ES cells revealed a rapid increase in ATM/ATR
phosphorylation targets γH2AX (S139), phospho-53BP1 (S166), and
phospho-SMC1 (S966), coincident with the loss of Sin3a (Fig. 5D).
Whereas H2AX and 53BP1 are hyperphosphorylated in response to
a variety of DSB types, SMC1 is typically phosphorylated by ATM as
part of the S-phase damage checkpoint (Kim et al., 2002; Yazdi et al.,
2002). An increase in the abundance of these markers is consistent
with DSBs arising during DNA replication in the absence of Sin3a.
From this, we conclude that Sin3a is required to prevent or repair
DSBs that arise in ES cells, possibly during DNA replication.
To test whether failure to resolve replicative damage could ac-
count for the apparent p53-independent apoptosis seen in mutant
ICMs, we next quantiﬁed levels of γH2AX in Sin3a−/− blastocysts
by immunoﬂuorescence. Intensity of anti-γH2AX staining was
measured in individual ICM and trophectoderm (TE) nuclei and
normalised to anti-Oct4 staining intensity in the same cells. Plotting
the resulting distributions reveals that both Sin3a−/− ICM and TE
cells indeed have signiﬁcantly increased H2AX staining as compared
to wild-type or heterozygous littermates (Fig. 6). It is important to
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cells of Sin3a−/− embryos (Fig. 3), highlighting the distinct repair
pathways in pluripotent vs. trophectoderm cells. Thus both the ex vivo
and in vivo results are consistent with unresolved DNA damage leading
to apoptosis of pluripotent cells in the absence of Sin3a.Sin3a associates with cell cycle control and DNA damage response
proteins in ES cells
Sin3a has been reported to interact with key cell cycle regulatory
proteins such as p53 and Rb, but these proteins play minor roles, if
any, in self-renewal of pluripotent cells. To gain a better understanding
of how Sin3a may interact with the cell cycle and/or DNA repair ma-
chinery in pluripotent cells, we took an unbiased approach toidentifying its interacting proteins in ES cells. An epitope-tagged
Sin3a protein was expressed in embryonic stem cells and used to pull
down the Sin3a complex and any interacting proteins (Fig. S1). The
identities of the major interacting proteins were determined by mass
spectrometry (Table 2).
This strategy identiﬁed known components of the Sin3a complex
with high peptide numbers and Mascot scores, whereas very few
peptides from complex members were obtained from cells expressing
the 3xFLAG epitope alone (Table 2). Data were obtained from four in-
dependent pull down experiments, providing a list of very high con-
ﬁdence interactors. The related protein Sin3b, which has been
reported to interact with Sin3a in NIH3T3 cells (Lienert et al., 2011),
was not signiﬁcantly enriched in the Sin3a immunoprecipitate com-
pared to control cells. This indicates that Sin3a and Sin3b function in-
dependently in ES cells, consistent with the dramatic difference in the
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and (Cowley et al., 2005; Dannenberg et al., 2005; David et al.,
2008)]. A number of known interactors implicated in control of cell
cycle and/or proliferation were found co-purifying with Sin3a in ES
cells, including Ogt (Hart et al., 2007; Yang et al., 2002), Ing1
(Nikolaev et al., 2004), Mnt (Meroni et al., 2000) and Max (Laherty
et al., 1997).
In addition to Sin3a complex components and known interactors,
we also identiﬁed a number of proteins not previously known to in-
teract with the Sin3a complex. Two of these novel interacting pro-
teins, Bbx and Ppp1cc, have been implicated in cell cycle control
(Lee et al., 2010a; Sánchez-Díaz et al., 2001). The interaction with
Bbx is particularly robust as it co-puriﬁes with Sin3a with scores
and peptide numbers comparable to those seen for bona ﬁde Sin3a
complex components. Notably, six of the high conﬁdence (Mascot
Scores ≥700) interacting proteins are phosphorylated upon DNA
damage by ATM or ATR (Matsuoka et al., 2007). Therefore we con-
clude that Sin3a is intimately linked to regulators of cell cycle and
the DNA damage response in ES cells.
Discussion
Gene regulation by a number of chromatin-modifying complexes
has been demonstrated to be important for early murine develop-
ment, but not necessarily for the survival of pluripotent cells (Niwa,
2007). The Sin3a/HDAC complex is a critical co-repressor of tran-
scription networks that govern cell cycle control, DNA replication
and repair, and apoptosis in somatic cells (Cowley et al., 2005;
Dannenberg et al., 2005). The requirement for genomic integrity dif-
fers considerably between somatic cells and pluripotent cells of the
ICM, and correspondingly so does the regulation of these vital pro-
cesses. Here we show that pluripotent cells exhibit a speciﬁc require-
ment for Sin3a function during early mouse development. Whereas
the epiblast compartment is completely lost in Sin3a mutant embryos
shortly after implantation, the trophectoderm cells remain largely un-
affected. Despite lacking key cell cycle regulatory proteins that inter-
act with Sin3a in somatic cells, Sin3a is required for proper cell cycle
control in both undifferentiated ES cells and in embryonic cells fullytwo days prior the point when they convert to canonical cell cycle
regulation (i.e. gastrulation at E6.5). Our data are consistent with
Sin3a speciﬁcally protecting pluripotent cells fromDNAdamage leading
to cell cycle arrest and elimination by apoptosis both in culture and in
implantation stage embryos.
The cell death phenotype we observe in the ICM upon Sin3a loss is
likely to be independent of p53, as we did not observe induction of
the direct p53 targets p21Cip, Apaf1, and Dram upon Sin3a deletion.
This is consistent with previous reports that deletion or inactivation
of p53 in MEFs fails to abrogate the growth and apoptosis phenotypes
caused by Sin3a deletion (Cowley et al., 2005; Dannenberg et al.,
2005) and reports that p53 is largely dispensable for apoptosis both
induced by double-stranded breaks in ES cells (Aladjem et al., 1998)
and as part of normal development prior to gastrulation (Armstrong
et al., 1995; Copp, 1978; El-Shershaby and Hinchliffe, 1974; Macleod
et al., 1995). However, the relationship between p53 and DNA damage
in pluripotent embryonic cells remains controversial (Corbet et al.,
1999; de Vries et al., 2002; Solozobova et al., 2009), andmore recent ev-
idence suggests p53maintains genomic stability in the early embryo by
suppressing pluripotency and promoting differentiation to eliminate
damaged cells (Lee et al., 2010b; Lin et al., 2005). Our data support
non-canonical roles for p53 in ES cells and suggest that parallel or
novel apoptotic pathways should be investigated more thoroughly in
the early embryo.
ICM cells deleted for Sin3a led to a loss of E2f1 and Ccn1e (Cyclin E)
expression and a dramatic decrease in both Mcm2 and Ccn1b (Cyclin
B) transcript levels. This increased repression is counter-intuitive, es-
pecially when considering that Mcm genes, Cdk/cyclins, and other
Myc/E2F targets are de-repressed in somatic cells lacking Sin3a
(Dannenberg et al., 2005). While this decrease in transcription
might simply be a consequence of cells whose proliferation has
been arrested at G2 by genotoxic stress (see below), the situation is
likely more complex in the ICM. In this rapidly proliferating cell
type, Myc and E2F targets that drive the cell cycle are very highly
expressed during all phases of the cell cycle (Fujii-Yamamoto et
al., 2005; Stead et al., 2002), so cells arrested at G2 should still ex-
press the factors that drive G1. The notable exception is Ccn1b (Cy-
clin B1), which is most highly expressed during G2 in ES cells
(Fujii-Yamamoto et al., 2005; Stead et al., 2002) to activate Cdk1
and promote mitotic entry. However, Ccnb1 levels are reduced in
ICM cells lacking Sin3a (Fig. 4A), the opposite result expected for
cells accumulated in G2.
The very high expression levels of Myc and E2F targets in wild-type
pluripotent embryonic cells demonstrate that they are not generally re-
pressed by Sin3a as they are in much of the soma. An alternative expla-
nation of our results, therefore, is that Sin3a, also robustly expressed in
ES cells and the ICM (Fig. 1A, Fig. 5A), facilitates the high expression of
Myc/E2F targets by indirectly activating the expression of Myc and E2Fs
themselves through repression of Myc/E2F repressors.
One category of possible Sin3a targets that repress Myc and E2F
expression would be miRNAs. Indeed, Myc is known to be downregu-
lated directly by the let-7 miRNA family (Kumar et al., 2007), whose
expression is normally kept very low in ES cells (Marson et al.,
2008; Tang et al., 2006a), and miR-294 is thought to promote Myc ac-
tivity in ES cells indirectly through repression of an unidentiﬁed Myc
repressor (Melton et al., 2010). Similarly, human E2f1 is repressed by
the miR-20 miRNA family (O'Donnell et al., 2005), whose members
are either nearly or completely undetectable in ES cells and the ICM
(Tang et al., 2006a, this study). While we did not observe de-
repression of let-7a, miR-20a, or miR-17-5p in ICMs lacking Sin3a, it
is possible that other members of these miRNA families, different
miRNAs altogether, or traditional protein repressors of Myc or E2f1
are instead misexpressed in these mutant cells, causing loss of Myc/
E2F target expression and abortion of the cell cycle.
Our combined observations of severe G2 arrest and phosphoryla-
tion of both H2AX and SMC1 upon Sin3a deletion suggest a speciﬁc
Table 2
Highest-scoring Sin3a interactors in ES cells.
Protein name Max
mascot
scorea
Unique
576b
Total
576c
Unique
590b
Total
590c
Unique
663E4b
Total
663E4c
Unique
663E5b
Total
663E5c
Control
Uniqueb
Control
Totalc
Entrez ID Comment
Sin3a 5086 64 458 59 537 55 717 58 605 0 0 20466 Sin3a complex component
Hdac1 2118 26 194 19 260 19 263 23 269 8 12 433759 Sin3a complex component
Arid4b 1867 25 75 18 64 29 107 19 76 3 3 94246 Sin3a complex component
Sap130 1849 21 140 23 166 22 216 23 185 4 4 269003 Sin3a complex component
Arid4a 1609 0 0 0 0 24 109 24 85 0 0 238247 Sin3a complex component
Rbbp7 1474 15 112 14 142 13 196 16 227 1 1 245688 Sin3a complex component
Hdac2 1341 19 141 13 116 17 155 20 159 0 0 15182 Sin3a complex component
Suds3 1309 18 124 15 119 16 177 15 156 0 0 71954 Sin3a complex component
Brms1l 1220 16 60 13 76 12 66 12 58 0 0 52592 Sin3a complex component
Rbbp4 1136 13 83 12 125 12 127 11 143 5 5 19646 Sin3a complex component
Ing2 1013 11 26 6 20 4 38 6 26 0 0 69260 Sin3a complex component
Sap30 892 13 53 6 53 9 60 7 46 0 0 60406 Sin3a complex component
Brms1 855 10 35 10 47 12 66 12 58 0 0 107392 Sin3a complex component
Sap30l 629 8 16 6 13 7 35 6 32 0 0 50724 Sin3a complex component
Sap25 316 5 11 3 3 1 2 1 2 0 0 751865 Sin3a complex component
Ogt 3371 43 84 33 110 27 123 27 80 1 1 108155 Known interactor: (Yang et al., 2002)
Bbx 1837 26 59 19 78 19 120 22 92 0 0 70508 HMG box transcription factor that is
necessary for cell cycle progression from
G1 to S phase (Sánchez-Díaz et al., 2001)
Tet1 1699 0 0 0 0 24 111 29 96 0 0 52463 Known interactor: (Williams et al., 2011)
Foxk2 1359 18 19 12 26 16 21 10 19 0 0 68837 Phosphorylated upon DNA damage, probably
by ATM or ATR: (Matsuoka et al., 2007)
Pspc1 1055 13 23 11 23 13 20 9 16 2 2 66645 Phosphorylated upon DNA damage, probably
by ATM or ATR: (Matsuoka et al., 2007)
Fam60a 901 11 34 12 53 8 49 11 52 0 0 56306 Phosphorylated upon DNA damage, probably
by ATM or ATR: (Matsuoka et al., 2007)
Phf23 765 6 16 9 25 4 21 5 21 0 0 78246 Phosphorylated upon DNA damage, probably
by ATM or ATR: (Matsuoka et al., 2007)
Bahcc1 726 7 14 10 16 4 5 7 11 2 2 268515 Phosphorylated upon DNA damage, probably
by ATM or ATR: (Matsuoka et al., 2007)
Foxk1 702 12 9 6 14 7 7 15 15 0 0 17425 Phosphorylated upon DNA damage, probably
by ATM or ATR: (Matsuoka et al., 2007)
2810046L04Rik 551 10 14 3 5 4 7 4 6 0 0 212127 Uncharacterised protein KIAA2032 homolog
Cbx3 499 2 10 6 2 0 0 0 0 2 2 12417 Hp1gamma
Zglp1 453 5 6 2 2 1 2 1 3 0 0 100009600 GATA-like protein 1
Ing1 428 8 13 2 18 4 38 2 23 0 0 26356 Known interactor: (Nikolaev et al., 2004).
Ppp1cc 369 6 5 4 7 0 0 5 5 0 0 19047 Implicated in cell cycle progression during
the transition from mitosis into interphase:
(Lee et al., 2010a)
Dnajb6 346 5 6 2 2 1 2 1 2 0 0 23950 DnaJ homolog subfamily B member 6
Mnt 332 5 5 1 1 0 0 3 3 0 0 17428 Known interactor: (Meroni et al., 2000)
Ythdf1 284 3 4 1 1 1 1 0 0 0 0 228994 YTH domain family protein 1
Hbp1 263 4 6 3 4 0 0 4 7 0 0 73389 Known interactor: (Swanson et al., 2004)
Klf13 242 2 2 3 3 2 2 1 1 0 0 50794 Known interactor: (Kaczynski et al., 2001)
Tet2 226 5 6 4 5 1 1 0 0 0 0 214133 Methylcytosine dioxygenase
H2afj 235 3 10 3 14 3 8 0 0 4 12 232440 Histone H2A.J
Hist2h2ac 235 3 10 3 14 3 8 0 0 0 0 8338 Histone H2A type 2-C
Max 188 2 3 1 1 2 2 1 1 0 0 17187 Known interactor: (Laherty et al., 1997)
a Maximum mascot score from the four different experiments.
b Number of unique peptides obtained from individual experiments.
c Total number of peptides obtained from individual experiments.
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during replication. However, the cause of this damage might be indi-
rect, especially considering that S. cerevisiae lacking Sin3p are hyper-
sensitive to DSBs, but not those speciﬁc to S phase (Jazayeri et al.,
2004). The reduced Mcm2 levels we observe in Sin3a-null ICMs
(Fig. 4A) provide a possible explanation. Mammalian cells with re-
ducedMcm levels are unable to activate a sufﬁcient number of origins
to support replication and are prone to stalled forks and double-
strand breaks that cause genomic instability and ultimately apoptosis
(Bailis et al., 2008; Ekholm-Reed et al., 2004). Because they lack a
functional G1 checkpoint, ES cells can readily initiate replication
without regard for genome integrity or sufﬁcient available materials
to complete the task. Without Sin3a, Mcm2 levels in the ICM are con-
siderably reduced, likely from the loss of E2F expression. If these cells
nevertheless enter S phase, then the resulting replicative damage
from insufﬁcient origins could lead to culling by the functional
G2/M damage checkpoint.It is nevertheless possible that Sin3a plays a more direct role in the
response to DNA damage in pluripotent cells. Sin3a directly interacts
with p53 and plays an important role in p53-mediated apoptosis in
somatic cells (Murphy et al., 1999), but p53 is dispensable in ES
cells and in early mouse embryos (Aladjem et al., 1998; Lin et al.,
2005; Solozobova et al., 2009). How, then, might the Sin3a complex
interact with the cell cycle and/or DNA repair machinery? Our identi-
ﬁcation of Sin3a interacting proteins in ES cells provides two possible,
non-exclusive explanations. Firstly we show that Sin3a in ES cells
co-puriﬁes with proteins implicated in cell cycle control. The
most abundant of these proteins are Ogt and Bbx. Ogt (O-linked
N-acetylglucosamine transferase) is an abundant, well-conserved pro-
tein implicated in a number of different cellular processes and required
for viability of embryonic stem cells (Hart et al., 2007; Shaﬁ et al., 2000).
Ogt has been shown to interact with Sin3a in HepG2 cells and the two
proteins were shown to act cooperatively in transcriptional repression
(Yang et al., 2002). Bbx, which also co-puriﬁes with Sin3a with similar
72 P. McDonel et al. / Developmental Biology 363 (2012) 62–73abundance as bona ﬁde Sin3a complex components (Table 2), is a rela-
tively uncharacterised HMG box-containing protein shown to comple-
ment a cell cycle defect in S. pombe (Sánchez-Díaz et al., 2001). Its
function in mammalian cells remains unknown. Secondly, our analysis
identiﬁed several Sin3a interacting proteins that becomephosphorylated
by ATM and/or ATR in response to DNA damage (Table 2), providing
a possible direct link between Sin3a and DNA damage response
pathways.
In conclusion, we have found that Sin3a is absolutely required
for the proliferation and survival of pluripotent embryonic cells
around the time of implantation. We propose that Sin3a is crucial for
regulating the pluripotent cell cycle by indirectly facilitating Myc and
E2F activity in the ICM. Loss of Myc/E2F target expression in Sin3a-
nulls causes reduced proliferation and errors in DNA replication, acti-
vating the stringent G2/M checkpoint that results in death of mutant
cells. This is in stark contrast to the situation in T cells or cells of the epi-
dermis, where Sin3a is not required for cellular proliferation (Cowley
et al., 2005; Nascimento et al., 2011), and provides insight into the mo-
lecular control of both the unusual cell cycle of pluripotent embryonic
cells and their genomic integrity.
Supplementary data to this article can be found online at doi:10.
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